Project Grant R01GM166612
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a $427,625 Project Grant to the University of Washington, effective September 1, 2025, through August 31, 2030, under the Biomedical Research and Research Training program (CFDA 93.859). This award supports the development of capillaric microfluidics technology for integrated, self-powered, and self-regulated sample preparation in miniaturized mass spectrometry (MS) systems. The research addresses a...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of Washington $2.1 million under its Biomedical Research and Research Training program (CFDA 93.859) for a project grant spanning May 1, 2026, through April 30, 2030. The award supports the development of ultrahigh multiplexing (>1,000-plex) spectrally barcoded fluorescent probes and methods for spatial transcriptomics applications. The primary deliverable is a set of over 1,024...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of Washington a $1.37M Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to develop novel analytical tools for monitoring proline isomerization in proteins. The four-year project, initiated June 1, 2026 and concluding May 31, 2030, focuses on expanding structural proteomics capabilities by combining tandem proteolysis, cold liquid chromatography,...
- Federal Project Grant Award Summary Nanoprobes Inc. received a $613,744 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, with completion targeted for February 28, 2027. The award supports the development of combined fluorescent and gold nanoparticle labeling reagents designed to advance Correlative Light and Electron Microscopy (CLEM) applications. The project...
- Federal Project Grant Award Summary Molariti Inc. received a $316,250 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) to develop novel solid-state nanopore array chip technology for biomolecule analysis. The award, effective September 1, 2025, through August 31, 2027, supports research aimed at creating scalable nanopore fabrication methods that overcome current limitations in existing...
- Federal Project Grant Award Summary Uforce Biotechnology, LLC received a $267,323 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) on May 15, 2025, with completion targeted for April 30, 2026. The award funds development of a quantum sensing device that integrates super-resolution force spectroscopy (SURFS) with ultrasound technology to accelerate drug development and improve screening...
- Federal Grant Award Summary The University of Massachusetts received a $396,854 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2029. The award supports the development of a nanopore tweezer toolkit designed to analyze kinase structural dynamics and screen allosteric inhibitors. This research leverages protein nanopore sensor technology to...
- Federal Grant Award Summary The University of Washington received a $397,158 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded April 1, 2026, with completion targeted for March 31, 2031. This five-year research initiative focuses on elucidating the biosynthesis pathways of halogenated nucleosides and nucleoside-sulfamates—naturally occurring pharmaceutical compounds produced by...
- Federal Grant Award Summary The National Science Foundation (NSF) Division of Molecular and Cellular Biosciences awarded the University of Washington a $836,598 Project Grant (CFDA 47.074, Biological Sciences) effective September 1, 2025, through August 31, 2030. This CAREER award funds research to develop tools and methodologies for reading and sequencing expanded genetic alphabets (XNA) containing synthetic nucleotide bases beyond the standard adenine, thymine, guanine, and cytosine. The...
- Federal Project Grant Award Summary The University of Washington received a $317,439 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded May 1, 2026, with completion targeted for January 31, 2030. The award funds development of Smoldyn, a widely-used spatial modeling software platform, to address critical gaps in cell biology simulation capabilities. The project will develop and implement...
The University of Washington received a $1.62 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) to develop and commercialize nanopore tweezers (NT), an ultra-precision single-molecule technique for studying enzyme motion along nucleic acids. The award, which runs from August 1, 2026 through July 31, 2030, funds critical technology advancement and standardization efforts to enable broader adoption of NT by the scientific and industrial communities. Key deliverables include precision calibration of applied force, development of open-source parallelized NT hardware, improvements to the ion current sensor, and establishment of NT assays for various nucleic-acid-processing enzymes. The nanopore tweezers technology represents a transformative advancement over existing single-molecule techniques, utilizing electronic measurements of ion currents through a protein nanopore sensor to track enzyme motion with sub-nucleotide precision and sub-millisecond temporal resolution while simultaneously identifying nucleotide sequences. This award specifically focuses on reducing technical complexity and implementation barriers so that laboratories without direct involvement from the University of Washington's research group can independently adopt and deploy the technology for studying enzyme kinetics and sequence-specific interactions at biological scales previously inaccessible with conventional methods.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.6m | 7/13/26 |